Novocure GmbH, based in Baar, Switzerland, specializes in innovative cancer treatment technologies, particularly through the development of Tumor Treating Fields (TTFields). This non-invasive therapy utilizes electric fields to disrupt cancer cell division, enhancing patient outcomes. The company focuses on advanced technologies such as electrode arrays, flexible transducer arrays, and conductive gel compositions, aiming to improve the efficacy of cancer treatments while minimizing side effects. Novocure is committed to advancing medical treatment apparatus and exploring the sensitivity of cancer cells to its therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

220 Patents

#5 in Baar

#82 in Switzerland

#3,889 in the World

Baar, Switzerland

Novocure Gmbh

Forward Citations = 3,004

136 inventors:

Yoram Wasserman (76 out of 86 patents)

Moshe Giladi (39 out of 39 patents)

Zeev Bomzon (38 out of 46 patents)

4. Tali Voloshin-Sela (30 out of 31 patents)

5. Yoram Palti (30 out of 95 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Novocure Gmbh. Retrieved from https://idiyas.com/company/novocure

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

13 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

167 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]